Regulatory agencies like the FDA and EMA have specific guidelines for the approval of new drug formulations. These include stringent requirements for toxicological assessments to ensure that any new formulation is as safe as, or safer than, existing options. Developers must provide comprehensive data on the formulation's safety, including any potential environmental impact.
